FI66600C - Foerfarande foer framstaellning av terapeutiskt aktiva 2-(laktam-n-acetamido)-acetamider - Google Patents

Foerfarande foer framstaellning av terapeutiskt aktiva 2-(laktam-n-acetamido)-acetamider Download PDF

Info

Publication number
FI66600C
FI66600C FI773069A FI773069A FI66600C FI 66600 C FI66600 C FI 66600C FI 773069 A FI773069 A FI 773069A FI 773069 A FI773069 A FI 773069A FI 66600 C FI66600 C FI 66600C
Authority
FI
Finland
Prior art keywords
formula
oxo
theory
yield
compound
Prior art date
Application number
FI773069A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI66600B (fi
FI773069A (fi
Inventor
Ludovic Rodriguez
Lucien Marchal
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of FI773069A publication Critical patent/FI773069A/fi
Publication of FI66600B publication Critical patent/FI66600B/fi
Application granted granted Critical
Publication of FI66600C publication Critical patent/FI66600C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
FI773069A 1976-10-22 1977-10-17 Foerfarande foer framstaellning av terapeutiskt aktiva 2-(laktam-n-acetamido)-acetamider FI66600C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB43934/76A GB1539817A (en) 1976-10-22 1976-10-22 N-substituted lactams
GB4393476 1976-10-22

Publications (3)

Publication Number Publication Date
FI773069A FI773069A (fi) 1978-04-23
FI66600B FI66600B (fi) 1984-07-31
FI66600C true FI66600C (fi) 1984-11-12

Family

ID=10431009

Family Applications (1)

Application Number Title Priority Date Filing Date
FI773069A FI66600C (fi) 1976-10-22 1977-10-17 Foerfarande foer framstaellning av terapeutiskt aktiva 2-(laktam-n-acetamido)-acetamider

Country Status (27)

Country Link
US (1) US4162325A (fr)
JP (1) JPS5839148B2 (fr)
AT (1) AT352742B (fr)
BE (1) BE859925A (fr)
BG (1) BG28413A3 (fr)
CA (1) CA1095040A (fr)
CH (1) CH625214A5 (fr)
CS (1) CS200231B2 (fr)
CY (1) CY1037A (fr)
DD (1) DD131930A5 (fr)
DE (1) DE2747369A1 (fr)
DK (1) DK461877A (fr)
ES (1) ES463424A1 (fr)
FI (1) FI66600C (fr)
FR (1) FR2368474B1 (fr)
GB (1) GB1539817A (fr)
HK (1) HK2380A (fr)
HU (1) HU174864B (fr)
IL (1) IL53171A (fr)
KE (1) KE3013A (fr)
MY (1) MY8000264A (fr)
NL (1) NL7711414A (fr)
PL (1) PL110679B1 (fr)
SE (1) SE425782B (fr)
SU (2) SU805945A3 (fr)
YU (1) YU251977A (fr)
ZA (1) ZA776260B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005689B1 (fr) * 1978-05-08 1981-03-18 U C B, S.A. Nouveaux acides lactame-N-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
EP0115472A3 (fr) * 1983-01-27 1985-10-02 Ciba-Geigy Ag Dérivés de la pyrrolidinone et leur procédé de préparation
EP0115473A3 (fr) * 1983-01-27 1987-01-21 Ciba-Geigy Ag Dérivés substitués de pyrrolidinone et leur procédé de préparation
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
US5118811A (en) * 1989-04-13 1992-06-02 Japan Tobacco Inc. Amino acid derivatives possessing prolyl endopeptidase-inhibitory activities
US5206386A (en) * 1991-03-20 1993-04-27 Isp Investments Inc. Controlled release N-substituted pyrrolidone esters and process for the use thereof
DE4308034A1 (de) * 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
US5658940A (en) * 1995-10-06 1997-08-19 Celgene Corporation Succinimide and maleimide cytokine inhibitors
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
CN114685342B (zh) * 2020-12-25 2024-05-10 长沙博源医疗科技有限公司 一种左乙拉西坦衍生物、免疫原、抗左乙拉西坦特异性抗体及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121723A (en) * 1955-11-02 1964-02-18 Sterling Drug Inc Lower alkyl n-(tertiary-amino-lower-alkyl) lower alkamates and quaternary ammonium salts thereof
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
NL7407140A (nl) * 1974-03-07 1975-09-09 Jose Maria Espinos Taya En Jos Werkwijze voor de bereiding van een n-gesub- stitueerd pyrrolidon.
AT360980B (de) * 1976-01-14 1981-02-10 Pliva Pharm & Chem Works Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins

Also Published As

Publication number Publication date
SE7711667L (sv) 1978-04-23
SE425782B (sv) 1982-11-08
FI66600B (fi) 1984-07-31
YU251977A (en) 1983-01-21
DD131930A5 (de) 1978-08-09
DE2747369A1 (de) 1978-04-27
JPS5353649A (en) 1978-05-16
KE3013A (en) 1980-02-01
SU937450A1 (ru) 1982-06-23
ATA749677A (de) 1979-03-15
HU174864B (hu) 1980-03-28
PL110679B1 (en) 1980-07-31
SU805945A3 (ru) 1981-02-15
PL201601A1 (pl) 1979-01-29
FR2368474B1 (fr) 1980-08-08
AT352742B (de) 1979-10-10
ZA776260B (en) 1978-07-26
IL53171A0 (en) 1977-12-30
CS200231B2 (en) 1980-08-29
CY1037A (en) 1980-08-01
IL53171A (en) 1982-02-28
HK2380A (en) 1980-01-25
DE2747369C2 (fr) 1987-11-12
DK461877A (da) 1978-04-23
NL7711414A (nl) 1978-04-25
BG28413A3 (en) 1980-04-15
FI773069A (fi) 1978-04-23
US4162325A (en) 1979-07-24
CH625214A5 (fr) 1981-09-15
CA1095040A (fr) 1981-02-03
ES463424A1 (es) 1978-07-16
FR2368474A1 (fr) 1978-05-19
JPS5839148B2 (ja) 1983-08-27
MY8000264A (en) 1980-12-31
BE859925A (fr) 1978-04-20
GB1539817A (en) 1979-02-07

Similar Documents

Publication Publication Date Title
FI66600C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 2-(laktam-n-acetamido)-acetamider
KR100636713B1 (ko) 신규의 ＶＬＡ－４ 억제제: ｏＭｅＰＵＰＡ－Ｖ
FI71556B (fi) Foerfarande foer framstaellning av 5-(paradeuterofenyl)-5-fenylhydantoin vilken aer ett laekemedel anvaendbart mot konvulsioner
NZ209187A (en) Benzoxazepine derivatives and pharmaceutical compositions
KR100308097B1 (ko) 1-아미노아세트아미도피롤1-아미노아세트아미도-2-(치환된)피롤및관련화합물과이를함유하는약제학적조성물
JPS63295588A (ja) 生理活性物質ｋ−２５２の誘導体
Speziale et al. N-Substituted glycinate and alaninate esters
NO156608B (no) Analogifremgangsmaate for fremstiling av terapeutisk aktive amider av 4-aminosmoersyre.
DK150064B (da) Analogifremgangsmaade til fremstilling af alfa-(2-hydroxyethyl)-2-oxo-1-pyrrolidineddikesyre samt amider deraf
EP0136274B1 (fr) Dérivés de 1-pipérazinecarboxamide, procédé de leur préparation et leur utilisation dans des compositions pharmaceutiques
IE57599B1 (en) Condensed,seven-membered ring compounds,their production and use
US5340809A (en) New 1-(alkoxybenzyl)piperazine amide compounds
US20100113504A1 (en) Amide compounds and their use as antitumor agents
US3907864A (en) Amino acid esters and amides of disubstituted phenethylamines
US4575514A (en) Anxiety alleviating compositions containing loweralkyl-N-[amino(arylaminocarbonyl)-iminomethyl]-N-methylglycinates
US4563477A (en) Process for the preparation of alpha-(N-pyrrolyl)-derivative acids, the salts and esters thereof; alpha-(N-pyrrolyl)-phenylacetic acids, the esters thereof, pharmaceutical compositions containing them and therapeutical applications thereof
US3637804A (en) Phenylalanine derivatives and preparation thereof
DE3204373A1 (de) Thiazaspiranderivate, verfahren zu ihrer herstellung und arzneimittel
FI59993B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-oxo-2-imidazolidinylidenurinaemnen
PT99050B (pt) Processo de preparacao de derivados de (2-tienil)alquilamina e de composicoes farmaceeuticas que os contem
JPH0566389B2 (fr)
FR2571723A1 (fr) Derives de thieno et furo-(2,3-c) pyrroles, procedes de preparation et medicaments les contenant
JPS63502432A (ja) アシル化シアナミド組成物
FI68218C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva di-n-propylmetylaminderivat
US4870056A (en) Acylated cyanamide composition

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: UCB S.A.